Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Application of a mouse model humanized for cytochrome P450–mediated drug metabolism to predict drug-drug interactions between a peptide and small molecule drugs

Title: Application of a mouse model humanized for cytochrome P450–mediated drug metabolism to predict drug-drug interactions between a peptide and small molecule drugs
Authors: Kapelyukh, Yury; Gabel-Jensen, Charlotte; MacLeod, Alastaire Kenneth; Coquelin, Kevin-Sebastien Daniel; Stojanovski, Laste; Frame, Laura; Tavendale, Amy; Henderson, Colin J.; Read, Kevin D.; Wolf, Charles Roland; Säll, Carolina
Source: Kapelyukh, Y, Gabel-Jensen, C, MacLeod, A K, Coquelin, K-S D, Stojanovski, L, Frame, L, Tavendale, A, Henderson, C J, Read, K D, Wolf, C R & Säll, C 2025, 'Application of a mouse model humanized for cytochrome P450–mediated drug metabolism to predict drug-drug interactions between a peptide and small molecule drugs', Drug Metabolism and Disposition, vol. 53, no. 10, 100153. https://doi.org/10.1016/j.dmd.2025.100153
Publication Year: 2025
Collection: Discovery - University of Dundee Online Publications
Subject Terms: Cytochrome P450; Drug-drug interaction predictions; Drug/drug interactions; Glucagon-like peptide 1; Humanized models; Peptide/small molecule drug-drug interaction; /dk/atira/pure/subjectarea/asjc/3000/3004; name=Pharmacology; /dk/atira/pure/subjectarea/asjc/3000/3003; name=Pharmaceutical Science
Description: Conventional preclinical in vitro approaches inaccurately predicted clinical trial outcomes of drug-drug interactions involving the peptide NN1177, a glucagon and glucagon-like peptide 1 receptor coagonist. To further study the mechanisms behind this discrepancy, we have exploited a mouse model (8HUM) humanized for the major cytochrome P450 (P450) enzymes involved in drug disposition in humans. We show that NN1177 administration to 8HUM mice suppressed hepatic in vivo expression of CYP3A4 (82% compared to vehicle) and CYP1A2 (58% compared to vehicle). This was consistent with in vitro sandwich culture hepatocyte data reported previously. However, reduction in CYP3A4 and CYP1A2 levels in vivo appeared to resolve over time, despite daily NN1177 administration. These findings suggest an adaptive response to the metabolic effects of NN1177. In vivo pharmacokinetic studies in 8HUM closely matched the findings observed in the clinical trial, because there was no relevant increase in the exposure of the CYP3A4 and CYP1A2 probe drugs. Furthermore, no suppression effects were observed when the mice had been pretreated with the inducing agents, St. John’s wort or phenobarbital, respectively, suggesting that the mechanism of P450 reduction does not involve the transcription factors constitutive androgen receptor or pregnane X receptor. These data highlight the complexities associated with therapeutic peptide drug-drug interactions and the remaining challenges for accurate predictions of P450 suppression and potential clinical implications. The humanized 8HUM model provides a promising and informative preclinical tool that can add high value during drug development by providing further insights into the effects on P450 expression, together with the subsequent impact of coadministered probe drugs in an in vivo model. Significance Statement: The current work describes the application of a humanized cytochrome P450 mouse model that provides further insight into the potential mechanisms and outperforms conventional in vitro ...
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 0090-9556; 1521-009X
Relation: info:eu-repo/semantics/altIdentifier/pmid/40972496; info:eu-repo/semantics/altIdentifier/pissn/0090-9556; info:eu-repo/semantics/altIdentifier/eissn/1521-009X
DOI: 10.1016/j.dmd.2025.100153
Availability: https://discovery.dundee.ac.uk/en/publications/80d096b0-d3c3-4704-aa28-26f099205129; https://doi.org/10.1016/j.dmd.2025.100153; https://discovery.dundee.ac.uk/ws/files/157423887/1-s2.0-S0090955625091627-main.pdf; https://www.scopus.com/pages/publications/105017697091
Rights: info:eu-repo/semantics/openAccess ; http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.4E856632
Database: BASE